Overview

* Harte Hanks ( HHS ) Q3 revenue fell due to timing and program transitions

* Net loss of $2.3 mln in Q3 vs net income of $0.1 mln last year

* Operating expenses down 14.7% yr/yr due to cost improvements

Outlook

* Harte Hanks ( HHS ) expects positive EBITDA for full-year 2025

* Company anticipates Q4 results to reflect new client opportunities

Result Drivers

* NEW PARTNERSHIP - Harte Hanks ( HHS ) highlights new partnership with Samsung as a key driver for pipeline replenishment and future growth

* COST IMPROVEMENTS - Operating expenses decreased 14.7% yr/yr due to strategic realignment efforts to offset revenue decline

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $39.52

Revenue mln

Q3 Net -$2.29

Income mln

Q3 $2.42

Adjusted mln

EBITDA

Q3 EBIT $509,000

Q3 $39.01

Operatin mln

g

Expenses

Q3 $319,000

Pretax

Profit

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)